A detailed history of Redmile Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Redmile Group, LLC holds 390,253 shares of BSX stock, worth $31.8 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
390,253
Previous 560,926 30.43%
Holding current value
$31.8 Million
Previous $38.4 Million 21.77%
% of portfolio
1.96%
Previous 1.51%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $11.5 Million - $13.3 Million
-170,673 Reduced 30.43%
390,253 $30.1 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $7.62 Million - $9.08 Million
-132,274 Reduced 19.08%
560,926 $38.4 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $14.7 Million - $17.5 Million
302,022 Added 77.21%
693,200 $40.1 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $10.9 Million - $12 Million
219,398 Added 127.72%
391,178 $21.2 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $7.75 Million - $8.59 Million
171,780 New
171,780 $8.59 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $47.1 Million - $59.7 Million
-1,422,049 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $18.1 Million - $22.2 Million
524,694 Added 58.47%
1,422,049 $54.3 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $27.1 Million - $35.1 Million
897,355 New
897,355 $31.5 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $42.1 Million - $74.6 Million
-1,631,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $61.8 Million - $74 Million
1,631,200 New
1,631,200 $73.8 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $15 Million - $18 Million
-603,493 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $15.8 Million - $17.6 Million
603,493
603,493 $17.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $117B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.